Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Translating biased signaling in the ghrelin receptor system into differential in vivo functions
A licensed prescriber (MD, DO, NP, or PA depending on state scope) must attest that the patient has no contraindications to GLP-1 therapy, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
Nausea is one of the most frequently reported side effects, affecting approximately 50% of patients taking GLP-1 medications, whilst vomiting occurs in about 15-25% of patients
In rough trial comparisons, Retatrutides TRIUMPH-1 data shows around 28.3% mean weight loss at 80 weeks on the 12 mg dose, with up to 30.3% at 104 weeks in a select extension population
US$ 26.73
US$ 21.48
US$ 28.58
US$ 23.38
US$ 22.14
US$ 27.33
US$ 26.79
